Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up [Yahoo! Finance]
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
Alvotech to produce Humira biosimilar for Cigna's Quallent [Seeking Alpha]
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab) [Yahoo! Finance]